(22) proposed that quantification of Elf3 levels in urinary exosomes may help to assess podocyte injury due to activation of transforming growth factor-β (TGF-β) signaling, which could be used as a new predictive marker for early diagnosis of DKD. This evidence concerns the gene ELF3 and diabetic kidney disease.